Epoch Investment Partners »

Halozyme Therapeutics shares owned by Epoch Investment Partners

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Epoch Investment Partners from 13F filings

Historical chart of Epoch Investment Partners investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Epoch Investment Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Epoch Investment Partners

Quarter filed Position value Share count Share price at filing
2024-09-30 $49M 853k 57.24
2024-06-30 $75M 1.4M 52.36
2024-03-31 $58M 1.4M 40.68
2023-12-31 $43M 1.2M 36.96
2023-09-30 $13M 332k 38.20
2023-06-30 $12M 332k 36.07
2023-03-31 $13M 332k 38.19
2022-12-31 $11M 188k 56.90